Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alao OO, Okwori OO, Egwu C, Audu F: Seroprevalence of Hepatitis B surface antigen among prospective Blood donor in an Urban Area of Benue state. The internet J of Hematology 2009.,5(2):
Lavanchy D: Hepatits B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J viral Hepatol 2004,11(2):97-107. 10.1046/j.1365-2893.2003.00487.x
Alavian Seyed-Moayed, Behnava Bita: What is the reason for poor outcome of Antepartum immunopoplylaxis of Heptatis B Immunoglobulin in prevention of vertical Hepatitis B Transmission? Heptatitis monthly 2007,7(3):163-165.
Schmidt M, Nubling CM, Scheiblanres H, Chudy M, Walch LA, Seifried E, Roth WK, Hourfar MK: Anti-HBC screening of blood donors: a comparison of nine anti-HBc test. Vox sang 2006, 91: 237-243. 10.1111/j.1423-0410.2006.00818.x
Hicks Rob: Hepatitis B.2009. [ http://www.bbc.co.uk/health/physical_health/conditions/hepatitisb1.shtml ]
Christopher S, William SM: Heptatis B virus Biology. Microbiology and Molecular Biology Reviews 2000,64(1):51-68. 10.1128/MMBR.64.1.51-68.2000
Cohen Sidney: Acute viral hepatitis. The Merck manual online Medical Library 2007. ©2006-2008
Gitlin Norman: Hepatitis B: diagnosis, Prevention and Treatment. Clinical Chemistry 1997,43:8(B):1500-1506.
Kumar H, Gupta PK, Jaiprakash BrigM: The role of anti-HBc IgM in Screening of Blood Donors. MJAFI 2007, 63: 350-352.
Geraldine K, Adel A, Intesar A, Jameel N, Said HA: Evidence of occult Hepatitis B Virus infection among Omani Blood Donors: A preliminary study. Medical Principle and Practice 15: 368-372.
Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T: High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis c virus related chronic liver disease in Japan. Gut 1999,45(2):284-288. 10.1136/gut.45.2.284
Panhotra BR, Bahrani A, Joshi CS, Ul Hassan Zahoor: Occult hepatitis B virus infection among anti HB c positive blood donors: Necessitates substitutionof screening by HBV NAT. J Infect 2005,51(3):263.
Hennig H, Puchta I, Luhm J, Luhm J, Schlenke P, Goerg S, Kirchner H: Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002, 100: 2637-41. 10.1182/blood-2002-03-0798
Muhlbacher A, Zdunek D, Melchior W, Michl U: Is infective blood donation missed out without screening for antibody to hepatitis B core antigen and/or hepatitis B virus DNA. Vox Sang 2001, 81: 139. 10.1046/j.1423-0410.2001.00086.x
Vyas GN: Significance of HBV DNA in HBsAg negative individuals: a critical commentary. In Transfusion associated hepatitis. Diagnosis, treatment and prevention. Edited by: Sarin SK, Hess G, eds. New Delhi: CBS Publishers & Distributors; 1998:49-56.
Chaudhuri V, Nanu A, Panda SK, Chand P: Evaluation of serologic screening for blood donors in India reveals a lack of correlation between anti-HB C titre and PCR amplified HBV DNA. Transfusion 2006,43(10):1442-1448.
Hoofnagle JH, Seef LB, Bales ZB, Zimmerman HJ: Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978, 298: 1379-83. 10.1056/NEJM197806222982502
Douglas DD, Taswell HF, Rakela J, Rabe D: Absence of hepatitis B DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993, 33: 212-6. 10.1046/j.1537-2995.1993.33393174446.x
Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, Edwards V: Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of Transfusion Transmitted Virus Study. Ann Intern Med 1984, 101: 733-8.
Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ: Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995, 35: 5-12. 10.1046/j.1537-2995.1995.35195090661.x
Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I: Serological pattern 'anti-HBc alone': Report on a workshop. J Med Virol 2000, 62: 450-5. 10.1002/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y
Allain JP: Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004, 86: 83-91. 10.1111/j.0042-9007.2004.00406.x
Ojo OS, Thursz M, Thomas HC, Ndububa DA, Adeodu oo, Rotimi O, Lawal AA, Durosimi MA, Akonai AK, Fatusi AO, Goldn RD: Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. East Afr Med J 1995,72(11):719-21.
Neirmeijer P, Gips CH: Viral antibodies and the infectivity of serum in hepatitis B. N Engl J Med 1978, 299: 958.
van Ditzhuijsen TJ, Selten GC, van Loon AM, Wolters G, Matthyssen L, Yap SH: Detection of hepatitis B DNA in serum and relation with the IgM class anti-HBc titres in hepatitis B infection. J Med Virol 1985, 15: 49-56. 10.1002/jmv.1890150107